Five stars earned
Notably, 48% of participants planned to take GLP-1RA indefinitely
These arent edge cases
100 Day Supply
Gubatan J, Kulkarni CV, Talamantes SM, Temby M, Fardeen T, Sinha SR
Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work